Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer is one of 9,000 studies in the ScholarPulse dataset. Key details — Authors: Julie R. Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried Eberhardt, Elena Poddubskaya; Journal / source: New England Journal of Medicine; Year: 2015.
| Authors | Julie R. Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried Eberhardt, Elena Poddubskaya |
|---|---|
| Journal / source | New England Journal of Medicine |
| Year | 2015 |
| Field | Cancer Immunotherapy and Biomarkers |
| Times cited | 8543 |
| Type | article |
| DOI / link | https://doi.org/10.1056/nejmoa1504627 |